324 results
Page 5 of 17
8-K
EX-99.1
8f3fh1n7b4 zq5ms4
24 Jul 20
Heron Therapeutics Receives Positive CHMP Opinion for ZYNRELEF™ (HTX-011) for the Management of Postoperative Pain
8:40am
8-K
EX-99.1
lfalrw8f ljclsf428r
16 Jul 20
Heron Therapeutics Announces Initiation of
8:40am
8-K
EX-99.1
2ps0ogvp
29 Jun 20
Heron Therapeutics Receives Complete Response Letter for HTX-011 for the Management of Postoperative Pain
4:06pm
8-K
EX-99.1
f5ksoxiwx5x3u3h
4 Jun 20
Regulation FD Disclosure
9:14am
8-K
EX-99.1
ptqeucetekxb4l5tv
18 May 20
Heron Therapeutics Announces Initiation of Phase 1b/2 Clinical Study of HTX-034 for the Treatment of Postoperative Pain
9:11am
8-K
EX-99.1
l8mcbmuab07e4mpffqk
6 May 20
Results of Operations and Financial Condition
9:10am
8-K
EX-99.1
f56h411
2 Mar 20
Results of Operations and Financial Condition
7:44am
8-K
EX-99.1
45y1jb9zbqzt 8hm
19 Feb 20
Heron Therapeutics Announces FDA Extension of Review Period for NDA for HTX-011 for the Management of Postoperative Pain
4:37pm
8-K
EX-99.1
smb7qp gp3cyyx9
13 Jan 20
Heron Therapeutics Highlights Progress in Pain Management and CINV Franchises
8:41am
8-K
EX-99.2
eif2l
13 Jan 20
Heron Therapeutics Highlights Progress in Pain Management and CINV Franchises
8:41am
8-K
EX-99.1
ypu1pn
16 Dec 19
Regulation FD Disclosure
4:15pm
8-K
EX-99.1
cqpo4
3 Dec 19
Health Canada Grants Priority Review Status for Heron Therapeutics’ New Drug Submission for HTX-011 for Management of Postoperative Pain
7:41am
8-K
EX-99.1
ihiypp
12 Nov 19
Results of Operations and Financial Condition
8:40am
8-K
EX-99.1
8e9cuk4x
28 Oct 19
Heron Therapeutics Announces FDA Acceptance of New Drug Application Resubmission for HTX-011 for Management of Postoperative Pain
8:41am
8-K
EX-99.1
qpx9w436gxxew0
22 Oct 19
Other Events
8:42am
8-K
EX-1.1
xfoiy h0ng
8 Oct 19
Entry into a Material Definitive Agreement
4:01pm
424B2
49zufija
7 Oct 19
Prospectus for primary offering
4:28pm